Cardiac metastases and tumor embolization: A rare sequelae of primary undifferentiated liver sarcoma  by Dua, Monica M. et al.
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INTRODUCTION:  Primary  hepatic  sarcomas  are  uncommon  malignant  neoplasms;  prognostic  features,
natural  history,  and  optimal  management  of these  tumors  are  not  well  characterized.
PRESENTATION  OF  CASE:  This  report  describes  the management  of a 51-year-old  patient  that  underwent  a
right  trisectionectomy  for a large  hepatic  mass  found  to be  a  liver  sarcoma  on  pathology.  He subsequently
developed  tumor  emboli  to his  lungs  and  was  discovered  to have  cardiac  intracavitary  metastases  from
his  primary  tumor.  The  patient  underwent  cardiopulmonary  bypass  and resection  of  the  right-sided  heart
metastases  to prevent  further  pulmonary  sequela  of  tumor  embolization.
DISCUSSION:  The  lack  of distinguishing  symptoms  or imaging  characteristics  that  clearly  deﬁne  hepatic
sarcomas  makes  it challenging  to achieve  a diagnosis  prior  to  pathologic  examination.  Metastatic  spreadardiac metastases
umor emboli
is  frequently  to  the  lung  or pleura,  but very  rarely  seen  within  the  heart.  Failure  to recognize  cardiac
metastatic  disease  will ultimately  lead  to  progressive  tumor  embolization  and  cardiac  failure  if left
untreated.
CONCLUSION:  The  most  effective  therapy  for primary  liver  sarcomas  is  surgery;  radical  resection  should
be  performed  if  possible  given  the  aggressive  nature  of  these  tumors  to progress  and  metastasize.
.  Pub
he  CC© 2014  The  Authors
access  article  under  t
. Introduction
Primary hepatic sarcomas are extremely rare tumors that com-
rise a heterogeneous group of histological subtypes including
ngiosarcoma, leiomyosarcoma, undifferentiated (embryonal) sar-
oma (UES), epithelioid hemangioendothelioma, and ﬁbrosarcoma.
n the adult population, these sarcomas, as a group, represent less
han 1% of liver malignancies1,2; the various histological compo-
itions, in addition to vague symptoms, lack of common tumor
arkers, and inconsistent imaging ﬁndings often make diagnosis
ifﬁcult with delays in subsequent treatment.
Abbreviations: CT, computed tomography; IVC, inferior vena cava; PE, pul-
onary emboli; UES, undifferentiated (embryonal) sarcoma; TVE, total vascular
xclusion.
∗ Corresponding author. Tel.: +1 650 736 1355; fax: +1 650 724 9806.
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J.M. Cloyd), fhaddad@stanford.edu (F. Haddad), rbeygui@stanford.edu (R.E. Beygui),
anorton@stanford.edu (J.A. Norton), bvisser@stanford.edu (B.C. Visser).
1 Tel.: +1 650 736 1355; fax: +1 650 724 9806.
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 BY-NC-ND  license  (http://creativecommons.org/licenses/by-nc-nd/3.0/).
2. Presentation of case
A 51-year-old male patient developed progressive right upper
quadrant abdominal pain over several weeks. He presented to a
local hospital with acute pain; computed tomography (CT) imaging
demonstrated a 28 cm complex cystic tumor with septal enhance-
ment, nodularity, and inferior vena cava (IVC) compression (Fig. 1).
Aspiration of the tumor was  noted to be initially hemorrhagic; this
was followed by percutaneous drainage and removal of 4L serosan-
guinous ﬂuid for symptom relief. The ﬂuid quickly re-accumulated
and he was transferred to our hepatobiliary surgical service for
further management.
Due to mass effect of the large tumor and resultant anatomic
stretch of the bile ducts, the patient was mildly jaundiced with an
elevated bilirubin level of 3.7 mg/dL and alkaline phosphatase level
of 509U/L. A percutaneous transhepatic biliary drain was  placed
into the left lateral segment of the liver for preoperative drainage
and his jaundice improved. The tumor had imaging features con-
cerning for malignancy, but minimal overall solid component;
therefore, the differential diagnosis included biliary cystadenoma,
cystadenocarcinoma, or less likely an intrahepatic sarcoma. There
ssociates Ltd. This is an open access article under the CC BY-NC-ND license
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Fig. 1. CT scan of primary liver sarcoma. Axial CT scan slice of a 28 cm complex,
multiloculated cystic mass with enhancing mural nodularity and septations pre-
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he was referred to cardiothoracic surgery for resection of the car-
F
eominantly in the right lobe of the liver and extending into the left medial section.
here is mass effect from the liver displacing the IVC and left portal vein.
as a strong probability that the tumor had bled both into itself
nd into the peritoneum adjacent to it (causing his acute onset
f symptoms); however, the cytology from the aspiration done at
he local hospital was negative for malignancy. He underwent a
ight trisectionectomy with caudate lobectomy via a thoracoab-
ominal approach (Fig. 2A) given the large tumor size (Fig. 2B).
espite division of the right liver inﬂow, the weight of the tumor
gainst the IVC produced a very high physiologic central venous
ressure. This did not permit an anterior approach to parenchy-
al  division; we  encountered brisk venous back-bleeding during
he initial attempt at transection. The right liver was mobilized and
he short hepatic veins and right hepatic vein were divided. Total
epatic vascular exclusion was obtained by placing one Rummel
ourniquet around the left liver inﬂow (for Pringle maneuver) and
nother tourniquet around the common middle and left hepatic
ein outﬂow. Two periods of vascular clamping were used to divide
he liver parenchyma; total occlusion time was 33 min. During the
peration, anesthesia had placed a transesophageal echocardio-
ram probe for routine continuous monitoring which suggested
 vegetation on the tricuspid valve – though the signiﬁcance of this
nding was uncertain so further evaluation was planned for after
urgery. The liver specimen weighed 4650 g and demonstrated a
eterogeneous mass with areas of hemorrhage and necrosis (Fig. 3).
istological sections demonstrated atypical spindled cells with
ig. 2. Resection technique and specimen. Operative photographs illustrating (A) the thora
xposure of the massive tumor; and (B) the specimen after right trisectionectomy.Fig. 3. Gross architecture of liver sarcoma. The specimen is bivalved to demonstrate
a heterogeneous mass of solid and cystic components with areas of hemorrhage and
necrosis.
hyperchromatic nuclei and multiple areas of necrosis consistent
with an undifferentiated liver sarcoma of intermediate-grade.
On post-operative day one, the patient developed hypoxia and
a CT angiogram of the chest demonstrated small, right-sided seg-
mental pulmonary emboli (PE). A transthoracic echocardiogram
conﬁrmed a mobile mass on the triscupid chordal apparatus. The
patient was anticoagulated and subsequent blood cultures grew
staphylococcus.  The combination of events seemed odd, but he was
presumptively diagnosed with endocarditis (believed to have been
present preoperatively) and placed on a 6-week regimen of antibi-
otics. He recovered without further sequela was discharged 11 days
after his initial operation. A repeat echocardiogram at 8 weeks
postoperatively demonstrated a second mass originating from the
right atrium and resultant pulmonary hypertension. Interval CT
angiogram of the chest also showed progressive pulmonary emboli,
despite being on therapeutic Lovenox. Finally at 10 weeks post-
operatively, repeat imaging showed an increased size of the mass
attached to the tricuspid chordal apparatus with extension into the
main pulmonary artery (Fig. 4A) as well as a second mobile mass
within the IVC originating from the left hepatic vein and extend-
ing into the right atrium (Fig. 4B). The bilateral pulmonary emboli
had increased in size and number, suggestive of truly being tumor
emboli from the cardiac mass.
Given such rapid progression and risk of further embolization,diac mass. A median sternotomy was performed and after initiation
of cardiopulmonary bypass, umbilical tapes were placed around
the superior and inferior vena cava. The right atrium was  opened
coabdominal extension used to split the costal margin and diaphragm for improved
CASE  REPORT  –  OPEN  ACCESS
M.M. Dua et al. / International Journal of Surgery Case Reports 5 (2014) 927–931 929
F sence of tumor in the main pulmonary artery on axial section (via extension of the right
v C and right atrium on coronal section. White arrow indicates tumor originating from the
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Fig. 5. Gross architecture of atrial mass. Fragments of the intracavitary cardiac
tumor consist of multiple grape-like clusters of soft tissue pedunculated on a stalk.
F
c
(ig. 4. CT scan of cardiac metastases. CT scan of the chest demonstrates (A) the pre
entricular mass through the pulmonic valve); and (B) tumor extension into the IV
eft  hepatic vein (only remaining hepatic vein after right trisectionectomy).
nd demonstrated the right ventricular mass below the tricus-
id valve and a right atrial mass with extension from the IVC.
he mass did not incorporate the valve or the myocardium and
ad the appearance of multiple rubbery cystic clusters peduncu-
ated on a stalk emanating from the hepatic vein (Fig. 5). As the
atient had undergone a right trisectionectomy, there was  only one
emaining hepatic vein entering the IVC. Fogarty embolectomy was
one through the left hepatic vein with no further tumor retrieved.
 transverse arteriotomy was made in the main pulmonary artery
or antegrade embolectomy and no additional masses or throm-
us was removed. The right atriotomy was closed and total aortic
ross-clamp time was 45 min. The patient recovered uneventfully
nd the pathology of the cardiac tumors was consistent with the
iver sarcoma primary.
An echocardiogram at one month postoperatively demonstrated
ormal systolic function, improvement in right ventricular systolic
ressures, and no residual masses. As the etiology of his pul-
onary emboli was more likely to have been fragments of friable
umor as opposed to true thrombus, the need for anticoagulation
as debatable; it was decided to maintain anticoagulation for 3
onths postoperatively from his second surgery – until he had
ecanalization of his pulmonary artery and therefore, lower risk
f thrombosis. A surveillance CT angiogram of the chest was  done
fter completion of anticoagulation therapy and this showed no
lling defects within the pulmonary arteries or the heart (Fig. 6).
e was referred to medical oncology for adjuvant chemotherapy
ith 6 cycles of Ifosfamide and Doxorubicin.
ig. 6. Postoperative CT angiogram. CT angiogram of the chest performed at three mo
oagulation therapy. There are no residual cardiac masses (A) and no pulmonary em
B).The histological sections demonstrated variable cellular myxoid proliferation and
spindled cells similar to the primary liver sarcoma.3. Discussion
As a result of its infrequency, treatment approaches for primary
hepatic sarcomas have not been standardized. Complete tumor
nths postoperatively (from intracavitary resection) and after completion of anti-
boli or abnormal ﬁlling defects noted within the cardio-pulmonary vasculature
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esection has been demonstrated to be the most effective ther-
py at present.1–3 The survival in most patients with unresectable
umors is poor, frequently surviving only a few months due to local
umor progression or early metastatic spread.4,5 Small series of
dult patients undergoing surgery suggest that tumor histology,6
umor grade,1,2 and completeness of resection are the most impor-
ant predictors of survival.1,2,5,6 The 5-year survival after primary
urgical treatment was reported between 64 and 77% in patients
ho underwent R0 resection; however, all patients in whom an R1
esection was performed died within three years. Local recurrence
s frequent despite complete resection, with two of the studies
eporting an intrahepatic recurrence rate of approximately 30%
ithin the ﬁrst three years.1,5 The presence of distant metastases
as the predominant reason for treatment failure with the lung,
leural, and peritoneal surfaces being the most common sites of
isease.1,7,8
The frequency of cardiac metastases varies from 12 to 25% of
ost-mortem patients who have died of malignancies.9,10 In one
eries of 407 cases in which the heart or pericardium was  sec-
ndarily involved with a malignant tumor, 4.2% of these tumors
ere from a sarcoma primary.11 Cardiac metastases mostly appear
n patients with advanced tumor disease; at this stage of disease,
any patients have undergone some type of treatment for the pri-
ary tumor. The most common tumors with cardiac metastatic
otential include carcinomas of the lung, breast and esophagus,
alignant lymphoma, leukemia and malignant melanoma.9
There are four pathways by which metastases may  reach the
eart – through lymphatic or hematogenous spread and by direct or
ransvenous extension. Cardiac intracavitary metastases are infre-
uent, with the atrium being more commonly involved than the
entricle.10 These metastases are usually secondary to transvenous
xtension into the right atrium as a result of embolization or prop-
gation along the vena cava. Our patient had no evidence of tumor
n the hepatic veins or IVC on preoperative imaging; therefore,
hrombectomy at the time of primary resection was not indicated.
athology conﬁrmed the mass to be conﬁned to the liver with
o vascular invasion and all margins negative. Operations for pri-
ary hepatic tumor with thrombus extending to the hepatocaval
onﬂuence are feasible, but remain challenging from a technical
nd hemodynamic standpoint given the need for total vascular
xclusion (TVE) to control hemorrhage.12 The majority of these
igh risk cases with TVE are done for retrohepatic or suprahep-
tic caval thrombus by direct extension; concurrent hepatectomy
ith cardiopulmonary bypass and removal of tumor thrombus
xtending to the right atrium has also been described.12,13 Although
ot diagnosed at the time of liver resection, our patient already
ad demonstrated propensity for tumor embolization (rather than
irect extension of thrombus) with the presence of his isolated
ntracavitary cardiac metastasis. Mechanical factors during blunt
obilization and rotation of the liver are unavoidable when dis-
ecting a large tumor and can be responsible for further tumor
islodgement or microembolization into the venous circulation
ith subsequent intracaval involvement.14
Several case reports of endometrial stromal sarcoma with
ntracardiac metastasis have been described, with the majority also
aving intracaval involvement.15,16 One such case that underwent
urgical treatment reported a thin and string-like rubbery mass (a
escription similar to our ﬁndings) which was easily removed from
he right ventricular outﬂow tract.16 As cardiac metastases usu-
lly remain clinically silent, most intracavitary tumors are found on
utopsy with less than 10% presenting with symptoms indicative
f cardiac dysfunction.9 Lack and colleagues examined the post-
ortem pathologic features of 16 children with UES of the liver
nd found two cases of hepatic vein invasion with extension up the
VC into the right atrium and ventricle. Both children died of pro-
ressive dyspnea and massive tumor embolization to the lungs.17PEN  ACCESS
rgery Case Reports 5 (2014) 927–931
Right-sided metastases can lead to pulmonary tumor emboli
with progressive cor pulmonale over weeks to months.18,19 Estab-
lishing the diagnosis of pulmonary tumor embolism can be difﬁcult
as dyspnea in a patient with cancer may  have several common
causes including infection, thromboembolism, metastatic disease,
or as a result of side effects from chemotherapy. Occlusion of the
pulmonary vasculature with tumor cells and associated throm-
bus can present a subacute and progressive clinical scenario that
resembles thromboembolic disease. Even in symptomatic patients,
identifying a true diagnosis of microscopic tumor embolism is
challenging as the diagnosis is under-recognized and radiographic
ﬁndings are nonspeciﬁc. Upon complaint of dyspnea, initial CT
angiogram of the chest in our patient demonstrated the pres-
ence of small ﬁlling defects in the segmental branches of the right
upper and middle lobe pulmonary arteries suggestive of pulmonary
emboli. The cardiac mass was initially believed to represent endo-
carditis and he was therefore treated with anticoagulation and
antibiotics. His treatment failure (evidenced by increased size of
the right heart mass and progressive pulmonary emboli on follow-
up exams) prompted re-evaluation of the diagnosis and surgical
intervention for the ongoing nature of his embolization.
Only a few adult cases of UES have been reported; how-
ever, this particular variety of hepatic sarcoma accounts for up
to 13% of pediatric hepatic malignancies, commonly occurring
in patients under the age of 10 years.4,8 Although a supportive
role of neoadjuvant/adjuvant chemotherapy is not conﬁrmed in
all primary hepatic sarcomas, experience in the pediatric pop-
ulation with adjuvant chemotherapy after complete resection
of UES has demonstrated improved survival compared with
patients who undergo surgical resection alone in this chemosensi-
tive subtype.3,20,21 More recently, aggressive multimodal therapy
including neoadjuvant therapy and liver transplantation have been
supported as a surgical option for patients whose tumors are ini-
tially unresectable or recur.4
4. Conclusion
The most effective therapy for primary liver sarcomas is surgery;
radical resection should be performed if possible given the aggres-
sive nature of these tumors to progress and metastasize. The
histologic subtype UES is uncommon in adults and therefore,
frequently gets misdiagnosed as benign disease due to its predom-
inantly cystic appearance and mucoid composition on CT imaging.
Operations are often technically difﬁcult because of the large size
(10–30 cm)  of these tumors but offer the best chance of survival in
combination with adjuvant chemotherapy. Local recurrences and
metastatic disease to lung, pleura and peritoneum are common;
metastases to the heart should also be considered in the differential
of cardiac lesions detected by echocardiography. Failure to recog-
nize cardiac metastatic disease will ultimately lead to progressive
tumor embolization and cardiac failure if left untreated.
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